DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Patch Test Skin Irritation/Sensitization of Cetaphil Daily Advance Ultra Hydration Lotion

Information source: Galderma Laboratories, L.P.
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Determine Sensitivity of Skin to Cetaphil Daily Advance Ultra Hydrating Lotion

Intervention: Cetaphil Daily Advance Ultra Hydrating Lotion (Other)

Phase: N/A

Status: Completed

Sponsored by: Galderma Laboratories, L.P.

Official(s) and/or principal investigator(s):
Mayya Tastene, MD, Principal Investigator, Affiliation: AMA Laboratories

Summary

Determine if Cetaphil Daily Advance Ultra Hydrating Lotion proves to be a contact sensitizer or irritant in certain individuals.

Clinical Details

Official title: 100 Human Subject Repeat Insult Patch Test Skin Irritation/Sensitization Evaluation (Occlusive Patch)

Study design: Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Primary outcome: area of erythema and edema is measured

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Not currently under a doctor's care

- Free of dermatological or systemic disorder which would interfere with the results

- Free of any acute or chronic disease

- Will complete a preliminary medical history form and are in general good health

- Can read, understand, and sign informed consent

Exclusion Criteria:

- Under 18 years old

- Currently under doctor's care

- currently taking any medication

- History of acute or chronic disease

- Diagnosed with chronic skin allergies

- Pregnant or lactating

Locations and Contacts

Additional Information

Starting date: December 2012
Last updated: June 19, 2013

Page last updated: August 20, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017